Advertisement

Lifetime Data Analysis

, Volume 23, Issue 2, pp 161–182 | Cite as

Landmark estimation of survival and treatment effects in observational studies

Article
  • 530 Downloads

Abstract

Clinical studies aimed at identifying effective treatments to reduce the risk of disease or death often require long term follow-up of participants in order to observe a sufficient number of events to precisely estimate the treatment effect. In such studies, observing the outcome of interest during follow-up may be difficult and high rates of censoring may be observed which often leads to reduced power when applying straightforward statistical methods developed for time-to-event data. Alternative methods have been proposed to take advantage of auxiliary information that may potentially improve efficiency when estimating marginal survival and improve power when testing for a treatment effect. Recently, Parast et al. (J Am Stat Assoc 109(505):384–394, 2014) proposed a landmark estimation procedure for the estimation of survival and treatment effects in a randomized clinical trial setting and demonstrated that significant gains in efficiency and power could be obtained by incorporating intermediate event information as well as baseline covariates. However, the procedure requires the assumption that the potential outcomes for each individual under treatment and control are independent of treatment group assignment which is unlikely to hold in an observational study setting. In this paper we develop the landmark estimation procedure for use in an observational setting. In particular, we incorporate inverse probability of treatment weights (IPTW) in the landmark estimation procedure to account for selection bias on observed baseline (pretreatment) covariates. We demonstrate that consistent estimates of survival and treatment effects can be obtained by using IPTW and that there is improved efficiency by using auxiliary intermediate event and baseline information. We compare our proposed estimates to those obtained using the Kaplan–Meier estimator, the original landmark estimation procedure, and the IPTW Kaplan–Meier estimator. We illustrate our resulting reduction in bias and gains in efficiency through a simulation study and apply our procedure to an AIDS dataset to examine the effect of previous antiretroviral therapy on survival.

Keywords

Treatment effect Survival analysis Intermediate event  Nonparametric Robust 

Supplementary material

10985_2016_9358_MOESM1_ESM.pdf (325 kb)
Supplementary material 1 (pdf 324 KB)

References

  1. Amato DA (1988) A generalized Kaplan-Meier estimator for heterogenous populations. Commun Stat 17(1):263–286CrossRefMATHGoogle Scholar
  2. Austin PC (2007) The performance of different propensity score methods for estimating marginal odds ratios. Stat Med 26(16):3078–3094MathSciNetCrossRefGoogle Scholar
  3. Austin PC (2009) Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28:3083–3107MathSciNetCrossRefGoogle Scholar
  4. Austin PC, Stuart EA (2015) Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med 34(28):3661–3679MathSciNetCrossRefGoogle Scholar
  5. Bai X, Tsiatis AA, O’Brien SM (2013) Doubly-robust estimators of treatment-specific survival distributions in observational studies with stratified sampling. Biometrics 69(4):830–839MathSciNetCrossRefMATHGoogle Scholar
  6. Beran R (1981) Nonparametric regression with randomly censored survival data. Technical report, University of California BerkeleyGoogle Scholar
  7. Bhatta L, Klouman E, Deuba K, Shrestha R, Karki DK, Ekstrom AM, Ahmed LA (2013) Survival on antiretroviral treatment among adult HIV-infected patients in Nepal: a retrospective cohort study in far-western region, 2006–2011. BMC Infect Dis 13(1):604CrossRefGoogle Scholar
  8. Breiman L, Friedman J, Stone CJ, Olshen RA (1984) Classification and regression trees. CRC Press, Boca RatonMATHGoogle Scholar
  9. Cai T, Tian L, Wei LJ (2005) Semiparametric Box-Cox power transformation models for censored survival observations. Biometrika 92(3):619–632MathSciNetCrossRefMATHGoogle Scholar
  10. Cai T, Tian L, Uno H, Solomon S, Wei L (2010) Calibrating parametric subject-specific risk estimation. Biometrika 97(2):389–404MathSciNetCrossRefMATHGoogle Scholar
  11. Chen PY, Tsiatis AA (2001) Causal inference on the difference of the restricted mean lifetime between two groups. Biometrics 57(4):1030–1038MathSciNetCrossRefMATHGoogle Scholar
  12. Cook R, Lawless J (2001) Some comments on efficiency gains from auxiliary information for right-censored data. J Stat Plan Inference 96(1):191–202CrossRefMATHGoogle Scholar
  13. Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc 34:187–220MathSciNetMATHGoogle Scholar
  14. Du Y, Akritas M (2002) Uniform strong representation of the conditional Kaplan-Meier process. Math Methods Stat 11(2):152–182MathSciNetMATHGoogle Scholar
  15. Faucett CL, Schenker N, Taylor JM (2002) Survival analysis using auxiliary variables via multiple imputation, with application to AIDS clinical trial data. Biometrics 58(1):37–47MathSciNetCrossRefMATHGoogle Scholar
  16. Fine J, Jiang H, Chappell R (2001) On semi-competing risks data. Biometrika 88(4):907–919MathSciNetCrossRefMATHGoogle Scholar
  17. Finkelstein DM, Schoenfeld DA (1994) Analysing survival in the presence of an auxiliary variable. Stat Med 13(17):1747–1754CrossRefGoogle Scholar
  18. Fleming TR, Prentice RL, Pepe MS, Glidden D (1994) Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS research. Stat Med 13(9):955–968CrossRefGoogle Scholar
  19. Garcia TP, Ma Y, Yin G (2011) Efficiency improvement in a class of survival models through model-free covariate incorporation. Lifetime Data Anal 17(4):552–565MathSciNetCrossRefMATHGoogle Scholar
  20. Gray R (1994) A kernel method for incorporating information on disease progression in the analysis of survival. Biometrika 81(3):527–539MathSciNetCrossRefMATHGoogle Scholar
  21. Griffin BA, Eibner C, Bird CE, Jewell A, Margolis K, Shih R, Slaughter ME, Whitsel EA, Allison M, Escarce JJ (2013) The relationship between urban sprawl and coronary heart disease in women. Health Place 20:51–61CrossRefGoogle Scholar
  22. Hammer S, Katzenstein D, Hughes M, Gundacker H, Schooley R, Haubrich R, Henry W, Lederman M, Phair J, Niu M et al (1996) A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. New Engl J Med 335(15):1081–1090CrossRefGoogle Scholar
  23. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ Jr, Feinberg JE, Balfour HH Jr, Deyton LR et al (1997) A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. New Engl J Med 337(11):725–733CrossRefGoogle Scholar
  24. Hankey BF, Myers MH (1971) Evaluating differences in survival between two groups of patients. J Chron Dis 24(9):523–531CrossRefGoogle Scholar
  25. Harder VS, Stuart EA, Anthony JC (2010) Propensity score techniques and the assessment of measured covariate balance to test causal associations in psychological research. Psychol Methods 15(3):234CrossRefGoogle Scholar
  26. Hernán MÁ, Brumback B, Robins JM (2000) Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 11(5):561–570CrossRefGoogle Scholar
  27. Higashi T, Shekelle PG, Adams JL, Kamberg CJ, Roth CP, Solomon DH, Reuben DB, Chiang L, MacLean CH, Chang JT et al (2005) Quality of care is associated with survival in vulnerable older patients. Ann Intern Med 143(4):274–281CrossRefGoogle Scholar
  28. Hill JL (2011) Bayesian nonparametric modeling for causal inference. J Comput Gr Stat 20(1):217–240MathSciNetCrossRefGoogle Scholar
  29. Hirano K, Imbens GW (2004) The propensity score with continuous treatments. Applied bayesian modeling and causal inference from incomplete-data perspectives: an essential journey with donald rubin’s statistical family. Wiley, New York, pp 73–84Google Scholar
  30. Imai K, Ratkovic M (2014) Covariate balancing propensity score. J R Stat Soc 76(1):243–263MathSciNetCrossRefGoogle Scholar
  31. Imai K, Van Dyk DA (2004) Causal inference with general treatment regimes. J Am Stat Assoc 99(467):854–866CrossRefMATHGoogle Scholar
  32. Imbens GW (2000) The role of the propensity score in estimating dose-response functions. Biometrika 87(3):706–710MathSciNetCrossRefMATHGoogle Scholar
  33. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53(282):457–481MathSciNetCrossRefMATHGoogle Scholar
  34. Lagakos S (1988) The loss in efficiency from misspecifying covariates in proportional hazards regression models. Biometrika 75(1):156–160MathSciNetCrossRefMATHGoogle Scholar
  35. Lagakos S, Schoenfeld D (1984) Properties of proportional-hazards score tests under misspecified regression models. Biometrics 40:1037–1048MathSciNetCrossRefMATHGoogle Scholar
  36. Lee BK, Lessler J, Stuart EA (2010) Improving propensity score weighting using machine learning. Stat Med 29(3):337–346MathSciNetGoogle Scholar
  37. Li Y, Taylor JM, Little RJ (2011) A shrinkage approach for estimating a treatment effect using intermediate biomarker data in clinical trials. Biometrics 67(4):1434–1441MathSciNetCrossRefMATHGoogle Scholar
  38. Liaw A, Wiener M (2002) Classification and regression by randomforest. R News 2(3):18–22Google Scholar
  39. Lin D (2000) On fitting cox’s proportional hazards models to survey data. Biometrika 87(1):37–47MathSciNetCrossRefMATHGoogle Scholar
  40. Lin D, Wei L (1989) The robust inference for the cox proportional hazards model. J Am Stat Assoc 84:1074–1078MathSciNetCrossRefMATHGoogle Scholar
  41. Lu X, Tsiatis A (2008) Improving the efficiency of the log-rank test using auxiliary covariates. Biometrika 95(3):679–694MathSciNetCrossRefMATHGoogle Scholar
  42. Marcus SM, Siddique J, Ten Have TR, Gibbons RD, Stuart E, Normand SLT (2008) Balancing treatment comparisons in longitudinal studies. Psychiatr Ann 38(12):805CrossRefGoogle Scholar
  43. McCaffrey DF, Ridgeway G, Morral AR (2004) Propensity score estimation with boosted regression for evaluating causal effects in observational studies. Psychol Methods 9(4):403CrossRefGoogle Scholar
  44. Mocroft A, Madge S, Johnson AM, Lazzarin A, Clumeck N, Goebel FD, Viard JP, Gatell J, Blaxhult A, Lundgren JD et al (1999) A comparison of exposure groups in the eurosida study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival. JAIDS 22(4):369–378Google Scholar
  45. Murray S, Tsiatis A (1996) Nonparametric survival estimation using prognostic longitudinal covariates. Biometrics 52:137–151CrossRefMATHGoogle Scholar
  46. Murray S, Tsiatis AA (2001) Using auxiliary time-dependent covariates to recover information in nonparametric testing with censored data. Lifetime Data Anal 7(2):125–141MathSciNetCrossRefMATHGoogle Scholar
  47. Nieto FJ, Coresh J (1996) Adjusting survival curves for confounders: a review and a new method. Am J Epidemiol 143(10):1059–1068CrossRefGoogle Scholar
  48. Normand SLT, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, Cleary PD, McNeil BJ (2001) Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 54(4):387–398CrossRefGoogle Scholar
  49. Pan Q, Schaubel DE (2008) Proportional hazards models based on biased samples and estimated selection probabilities. Can J Stat 36(1):111–127MathSciNetCrossRefMATHGoogle Scholar
  50. Parast L, Tian L, Cai T (2014) Landmark estimation of survival and treatment effect in a randomized clinical trial. J Am Stat Assoc 109(505):384–394MathSciNetCrossRefGoogle Scholar
  51. Park Y, Wei LJ (2003) Estimating subject-specific survival functions under the accelerated failure time model. Biometrika 90:717–23MathSciNetCrossRefMATHGoogle Scholar
  52. Patel K, Williams PL, Seeger JD, McIntosh K, Van Dyke RB, Seage GR et al (2008) Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis 46(4):507–515CrossRefGoogle Scholar
  53. Robins JM, Hernán MÁ, Brumback B (2000) Marginal structural models and causal inference in epidemiology. Epidemiology 11(5):550–560CrossRefGoogle Scholar
  54. Rosenbaum PR, Rubin DB (1983a) Assessing sensitivity to an unobserved binary covariate in an observational study with binary outcome. J R Stat Soc 45:212–218Google Scholar
  55. Rosenbaum PR, Rubin DB (1983b) The central role of the propensity score in observational studies for causal effects. Biometrika 70(1):41–55MathSciNetCrossRefMATHGoogle Scholar
  56. Rosenbaum PR, Rubin DB (1984) Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 79(387):516–524CrossRefGoogle Scholar
  57. Rotnitzky A, Robins J (2005) Inverse probability weighted estimation in survival analysis. Encycl Biostat 4:2619–2625Google Scholar
  58. Stuart EA, Lee BK, Leacy FP (2013) Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research. J Clin Epidemiol 66(8):S84–S90CrossRefGoogle Scholar
  59. Therneau TM (2000) Modeling survival data: extending the Cox model. Springer, New YorkCrossRefMATHGoogle Scholar
  60. Thomsen BL, Keiding N, Altman DG (1991) A note on the calculation of expected survival, illustrated by the survival of liver transplant patients. Stat Med 10(5):733–738CrossRefGoogle Scholar
  61. Tian L, Cai T, Goetghebeur E, Wei L (2007) Model evaluation based on the sampling distribution of estimated absolute prediction error. Biometrika 94(2):297–311MathSciNetCrossRefMATHGoogle Scholar
  62. Tian L, Cai T, Zhao L, Wei LJ (2012) On the covariate-adjusted estimation for an overall treatment difference with data from a randomized comparative clinical trial. Biostatistics 13(2):256–273CrossRefGoogle Scholar
  63. van der Laan MJ (2014) Targeted estimation of nuisance parameters to obtain valid statistical inference. Int J Biostat 10(1):29–57MathSciNetGoogle Scholar
  64. Van Houwelingen J, Putter H (2012) Dynamic prediction in clinical survival analysis. CRC Press, New YorkMATHGoogle Scholar
  65. Wood E, Hogg RS, Yip B, Harrigan PR, O’Shaughnessy MV, Montaner JS (2003) Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy? AIDS 17(5):711–720CrossRefGoogle Scholar
  66. Xie J, Liu C (2005) Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Stat Med 24(20):3089–3110MathSciNetCrossRefGoogle Scholar
  67. Zhang M (2015) Robust methods to improve efficiency and reduce bias in estimating survival curves in randomized clinical trials. Lifetime Data Anal 2014:1–19MathSciNetMATHGoogle Scholar
  68. Zhang M, Schaubel DE (2012a) Contrasting treatment-specific survival using double-robust estimators. Stat Med 31(30):4255–4268MathSciNetCrossRefGoogle Scholar
  69. Zhang M, Schaubel DE (2012b) Double-robust semiparametric estimator for differences in restricted mean lifetimes in observational studies. Biometrics 68(4):999–1009MathSciNetCrossRefMATHGoogle Scholar
  70. Zhang M, Tsiatis AA, Davidian M (2008) Improving efficiency of inferences in randomized clinical trials using auxiliary covariates. Biometrics 64(3):707–715MathSciNetCrossRefMATHGoogle Scholar
  71. Zhao L, Cai T, Tian L, Uno H, Solomon S, Wei L (2010) Stratifying subjects for treatment selection with censored event time data from a comparative study. Harvard University Biostatistics Working Paper Series, p 122Google Scholar
  72. Zhu Y, Coffman DL, Ghosh D (2015) A boosting algorithm for estimating generalized propensity scores with continuous treatments. J Causal Inference 3(1):25–40CrossRefGoogle Scholar

Copyright information

© RAND Corporation 2016

Authors and Affiliations

  1. 1.RAND CorporationSanta MonicaUSA

Personalised recommendations